Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral load detectability profiles for HIV infection.

Elizabeth J McKinnon1, Ian R James, Mina John

  • 1Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Western Australia, Australia. mckinnon@murdoch.edu.au

Statistics in Medicine
|January 17, 2003
PubMed
Summary

Many HIV patients on antiretroviral therapy achieve undetectable viral loads, but some experience a rebound. This study models viral load detectability over time to understand treatment response and factors influencing viral load changes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Central Nervous System T-cell immune architecture, and not HIV burden, tracks with cognition under long-term viral suppression.

PLoS pathogens·2026
Same author

Topical glyceryl trinitrate for increasing radial arterial diameter in neonates: a randomised controlled trial.

Pediatric research·2026
Same author

A quantitative metabolic signature of host response during SARS-CoV-2 infection and recovery.

iScience·2026
Same author

Author Correction: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis.

Nature·2026
Same author

The impact of accumulating immune adaptation in circulating strains of HIV-1.

HIV medicine·2026
Same author

Blinatumomab limits humoral antibody response despite boosting the influenza vaccine schedule in children with B-ALL.

Blood advances·2026

Area of Science:

  • Immunology
  • Virology
  • Biostatistics

Background:

  • Antiretroviral therapy (ART) significantly reduces HIV RNA levels, often to undetectable concentrations.
  • A substantial proportion of patients on ART experience viral load rebound after initial undetectability.
  • Understanding viral load dynamics is crucial for assessing long-term treatment efficacy.

Purpose of the Study:

  • To estimate proportions of undetectable HIV viral load over time post-ART initiation.
  • To model transitions between detectable and undetectable viral load states.
  • To investigate the impact of baseline covariates, such as CD4 T-cell counts, on virologic response.

Main Methods:

  • Parametric modeling of survival distributions to construct "detectability profiles".

Related Experiment Videos

  • Analysis of transition rates between detectable and undetectable viral load states.
  • Application to data from the Western Australian HIV Cohort Study.

    • Main Results:

    • Detectability profiles provide estimates of viral load undetectability over time.
    • The model can incorporate covariates to assess their influence on viral load dynamics.
    • Baseline CD4 T-cell counts were examined for their effect on virologic response.

    Conclusions:

    • Detectability profiles offer a robust method for evaluating virologic response to HIV therapy.
    • Modeling viral load transitions helps identify factors associated with sustained viral suppression.
    • This approach aids in understanding and optimizing long-term HIV management strategies.